Structure Therapeutics Quote - GPCR

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

43.01

Bid

43.05

Offer

44.44

Volume

1,400,939

43.01 Day's Range 45.68

0.00 52 Week Range 0.00

Market Cap

Previous Close

45.57

Open

45.14

Last Trade

43.68

Last Trade Time

Financial Volume

US$ 61,962,320

VWAP

44.2291

Average Volume (3m)

Shares Outstanding

46,621,123

Dividend Yield

PE Ratio

Earnings Per Share (EPS)

Revenue

Net Profit

Structure Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing oral treatments for chronic metabolic and pulmonary conditions. It develops oral small molecule therapeutics for the treatment of various diseases, including those impactin... Structure Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing oral treatments for chronic metabolic and pulmonary conditions. It develops oral small molecule therapeutics for the treatment of various diseases, including those impacting the metabolic, cardiovascular, and pulmonary systems. Its initial focus is on G-protein-coupled receptors as a therapeutic target class. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor for the treatment of type-2 diabetes mellitus and obesity. It is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases. Specifically, it is advancing ANPA-0073, its biased agonist, targeting the apelin receptor. It is also developing LTSE-2578, an investigational oral small molecule LPA1R antagonist for the treatment of idiopathic pulmonary fibrosis. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.structuretx.com

Headquarters

Grand Cayman, Cym

Founded

1970

Structure Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GPCR. The last closing price for Structure Therapeutics was US$45.57. Over the last year, Structure Therapeutics shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Structure Therapeutics currently has 46,621,123 shares in issue.

Overall Flow

Bearish

Net Premium

-89k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares

SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OAROAR Resources Limited	AUD 0.002 (100.00%)	1.25M
VN8Vonex Ltd	AUD 0.035 (94.44%)	18.93M
BGEBridge SaaS Ltd	AUD 0.016 (33.33%)	152.26k
EDEEden Innovations Ltd	AUD 0.002 (33.33%)	6.03M
ALRAltair Minerals Ltd	AUD 0.004 (33.33%)	25k
TD1Tali Digital Limited	AUD 0.001 (-50.00%)	75.66k
ABEAustralian Bond Exchange Holdings Ltd	AUD 0.013 (-35.00%)	163.72k
BFCBeston Global Food Company Limited	AUD 0.002 (-33.33%)	449.68k
CLZClassic Minerals Limited	AUD 0.001 (-33.33%)	354.1k
PRXProdigy Gold NL	AUD 0.002 (-33.33%)	30.72k
TM1Terra Metals Ltd	AUD 0.08 (9.59%)	52.98M
PURPursuit Minerals Limited	AUD 0.003 (0.00%)	50.08M
REDRed 5 Limited	AUD 0.385 (-6.67%)	40.99M
MTLMantle Minerals Limited	AUD 0.002 (0.00%)	33.58M
RFGRetail Food Group Limited	AUD 0.078 (0.00%)	30.89M